4-苯基-1,2-噁唑-3-胺 → (R)-3-Hydroxy-1-[(4-phenyl-isoxazol-3-ylcarbamoyl)-methyl]-1-azonia-bicyclo[2.2.2]octane bromide

HRID 2240297笔记

反应方程式

HRID 2240297 反应方程式
[Br-:1].[OH:2][C@@H:3]1[CH:8]2[CH2:9][CH2:10][N+:5]([CH2:11][C:12](=[O:19])[NH:13][C:14]3[CH:18]=[CH:17][O:16][N:15]=3)([CH2:6][CH2:7]2)[CH2:4]1.[C:20]1(C2C(N)=NOC=2)[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1>NC1C=CON=1>[Br-:1].[OH:2][C@@H:3]1[CH:8]2[CH2:9][CH2:10][N+:5]([CH2:11][C:12](=[O:19])[NH:13][C:14]3[C:18]([C:20]4[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=4)=[CH:17][O:16][N:15]=3)([CH2:6][CH2:7]2)[CH2:4]1

参与物

4

实验过程

This compound is prepared by an analogous method to (R)-3-hydroxy-1-(isoxazol-3-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2]octane bromide (Intermediate A) by replacing in 3-aminoisoxazol in step (Ai) with 4-phenylisoxazol-3-ylamine.

来源与证据

ORD记录
ord-9f4eb453ffb94438b2df4c47c86235f4
来源数据集
uspto-grants-2010_05
专利号
US07723356B2

反应笔记

加载中…